Home > Drug Search >
  • company_query: Alphamab
  •   > 
Drug Filter
Category:
chemistry (2) biology (25)
Status:
Approved (3) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (13) Phase Ⅰ (7)
Clinical Stage:
Pending (1) Active (23)
Bio-Type:
Gene therapy (1) Blood extraction (1) Microbial extract (1) Recombinant coagulation factor (1) Recombinant cytokines (1) Whole antibody (7) Fusion protein (3)
Indication:
Amyotrophic lateral sclerosis (ALS) (1) Breast cancer (1) Rectal cancer (1) Neuronal ceroid lipofuscinoses (1) Gastric cancer (1) HBV infection (1) HCV infection (2) HIV infection (1) Blepharospasm (1) Glabellar line (1) Rabies (1) Multiple sclerosis (MS) (1) Erythropoietic protoporphyria (1) Overactive bladder (OAB) (1) Pancreatic cancer (1) Postherpetic neuralgia (PHN) (1) Prostate cancer (1) Rheumatoid arthritis (RA) (3) Solid tumours (2) Type 2 diabetes (2) Colorectal cancer (2) Primary humoral immunodeficiency (1) Neutropenia (2) Progressive supranuclear palsy (1) Glioma (1) Clostridial infection (1) Allergic asthma (1) Hemophilia (1) Immune thrombocytopenic purpura (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top